Related Experiment Video
Updated: Jul 14, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Genetic screening for pheochromocytoma: should SDHC gene analysis be included?
M Mannelli1, T Ercolino, V Giachè
1Endocrinology, Department of Clinical Physiopathology, University of Florence, Florence, Italy. m.mannelli@dfc.unifi.it
Abstract:
PGL3 syndrome is caused by mutations in the SDHC gene. At present, only a few families affected by SDHC mutations have been reported in the literature and in each of them the clinical presentation was characterised by paragangliomas located only in the head and neck regions. No evidence of thoracic or abdominal catecholamine-secreting chromaffin tumours has been reported to date. We report the case of a 15-year-old girl with hypertension and a norepinephrine-secreting abdominal paraganglioma who was found to harbour a novel nonsense SDHC mutation, demonstrating that the clinical presentation of PGL3 syndrome can be more diverse than expected.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023